Physician profile
Ryan J Koene
NPI 1639464498
$14,016.36
in general payments reported to CMS, 2019-2025
17 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,758 · 2020: $29.35 · 2021: $1,462 · 2022: $506 · 2023: $2,578 · 2024: $514 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,269 · Travel and Lodging: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,269.29 |
| Travel and Lodging | $991.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,345.96 | 2019 | |
| Abbott Laboratories | $4,237.84 | 2019-2025 | Ensite Precision, Ensite, Tendril |
| Boston Scientific Corporation | $2,451.65 | 2019-2024 | Rhythmia Mapping System, Watchman Flx, S-Icd System Magnet |
| Medtronic, INC. | $1,103.02 | 2021-2025 | Affera Mapping System, Na, Arctic Front Advance |
| Biotronik INC. | $590.48 | 2019 | |
| Atricure, INC. | $507.62 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Biosense Webster, INC. | $170.98 | 2019-2024 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.04 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $131.00 | 2023-2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $106.59 | 2019-2024 | |
| Masimo Corporation | $79.57 | 2023 | Patient Safetynet System |
| Terumo Medical Corporation | $48.48 | 2022-2023 | Angio-Seal |
| Abiomed | $34.33 | 2023 | Impella |
| Impulse Dynamics (USA) INC. | $23.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.59 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Koene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.